相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe
Alexander Zoufaly et al.
PLOS ONE (2014)
CD4 Counts of Nonperinatally HIV-Infected Youth and Young Adults Presenting for HIV Care Between 2002 and 2010
Allison L. Agwu et al.
JAMA PEDIATRICS (2014)
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment
Giuseppe Lapadula et al.
AIDS (2013)
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
Amanda Mocroft et al.
PLOS MEDICINE (2013)
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients
Lars Peters et al.
AIDS (2012)
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort
Steven F. L. van Lelyveld et al.
AIDS (2012)
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
Peter W. Hunt et al.
AIDS (2011)
Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007
Bakhao Ndiaye et al.
BMC INFECTIOUS DISEASES (2011)
Late presentation of HIV infection: a consensus definition
A. Antinori et al.
HIV MEDICINE (2011)
Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral Therapy
A. Zoufaly et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy
Martin Potter et al.
AIDS (2010)
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV
Jacqueline Neuhaus et al.
AIDS (2010)
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART
Marta Massanella et al.
AIDS (2010)
Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study
Frederik N. Engsig et al.
BMC INFECTIOUS DISEASES (2010)
Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
Amanda Mocroft et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression
Mona R. Loutfy et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal Antiretroviral Therapy Cohort Collaboration (ART-CC)
Amanda Mocroft et al.
CLINICAL INFECTIOUS DISEASES (2009)
Hepatitis C Virus Infection and the Risk of Coronary Disease
Adeel A. Butt et al.
CLINICAL INFECTIOUS DISEASES (2009)
Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic Suppression
David M. Moore et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression
Lars Peters et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy
Felix Gutierrez et al.
CURRENT HIV RESEARCH (2008)
Evolution of Antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study
L. Sighinolfi et al.
INFECTION (2008)
Clinical outcome of HIV-infected anti retroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy
Ruimin Tan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Predictors of AIDS-defining events among advanced naive patients after HAART
Carlo Torti et al.
HIV CLINICAL TRIALS (2007)
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3
Bryan Lau et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
Giulia Marchetti et al.
AIDS (2006)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy
DM Moore et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/μL in HIV type 1-infected individuals receiving potent antiretroviral therapy
GR Kaufmann et al.
CLINICAL INFECTIOUS DISEASES (2005)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression
F Dronda et al.
CLINICAL INFECTIOUS DISEASES (2002)
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy
S Grabar et al.
ANNALS OF INTERNAL MEDICINE (2000)
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe -: Results from the EuroSIDA Study
R Paredes et al.
ARCHIVES OF INTERNAL MEDICINE (2000)